Profiel
Graham Melrose is the founder of Recce Pharmaceuticals Ltd., which was founded in 2007.
He held the title of Executive Director & Chief Research Officer from 2019 to 2020.
Dr. Melrose is also the founder of Chemeq Ltd.
In his former job, he was the Executive Director & Head-Research at Johnson & Johnson (Austrial) Pty Ltd.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
RECCE PHARMACEUTICALS LTD.
18.16% | 18-09-2023 | 37 028 311 ( 18.16% ) | 16 M $ | 30-04-2024 |
Eerdere bekende functies van Graham Melrose
Bedrijven | Functie | Einde |
---|---|---|
RECCE PHARMACEUTICALS LTD | Oprichter | 03-07-2020 |
Chemeq Ltd.
Chemeq Ltd. BiotechnologyHealth Technology Chemeq Ltd. develops, manufactures and markets polymeric antimicrobials drugs for the control of disease causing bacteria in commercial animal production. It is focused on its CHEMEQ® polymeric antimicrobial for the prevention and control of intestinal bacterial diseases in feedstock animals such as pigs and poultry. The company was founded in 1985 and is headquartered in Rockingham, Australia. | Oprichter | - |
Johnson & Johnson (Austrial) Pty Ltd. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
RECCE PHARMACEUTICALS LTD | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Johnson & Johnson (Austrial) Pty Ltd. | |
Chemeq Ltd.
Chemeq Ltd. BiotechnologyHealth Technology Chemeq Ltd. develops, manufactures and markets polymeric antimicrobials drugs for the control of disease causing bacteria in commercial animal production. It is focused on its CHEMEQ® polymeric antimicrobial for the prevention and control of intestinal bacterial diseases in feedstock animals such as pigs and poultry. The company was founded in 1985 and is headquartered in Rockingham, Australia. | Health Technology |